Clinical Trial Update: Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial update evaluates the efficacy and safety of concurrent chemoradiotherapy using oral vinorelbine in patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Vinorelbine (oral) (Vinorelbine)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Vinorelbine | Phase 2 | Status: ACTIVE_NOT_RECRUITING